Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

University Hospital Coventry

PubMed
Indexed incrossrefpubmed

Abstract

UNLABELLED: Type 2 diabetes (T2DM) is associated with chronic low-grade inflammation. Adipose tissue (AT) may represent an important site of inflammation. 3T3-L1 studies have demonstrated that lipopolysaccharide (LPS) activates toll-like receptors (TLRs) to cause inflammation. For this study, we 1) examined activation of TLRs and adipocytokines by LPS in human abdominal subcutaneous (AbdSc) adipocytes, 2) examined blockade of NF-kappaB in human AbdSc adipocytes, 3) examined the innate immune pathway in AbdSc AT from lean, obese, and T2DM subjects, and 4) examined the association of circulating LPS in T2DM subjects. The findings showed that LPS increased TLR-2 protein expression twofold (P

Citation impact

1,040
total citations
FWCI
15.15
Percentile
100%
References
42
Citations per year

Authors

9

Topics & keywords

Keywords
  • Internal medicine
  • Endocrinology
  • Inflammation
  • Adipose tissue
  • Lipopolysaccharide
  • Adipokine
  • Innate immune system
  • Tumor necrosis factor alpha
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.